Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004035316 | SCV004909733 | uncertain significance | Inborn genetic diseases | 2023-10-17 | criteria provided, single submitter | clinical testing | The c.350G>A (p.R117Q) alteration is located in exon 2 (coding exon 2) of the ASPM gene. This alteration results from a G to A substitution at nucleotide position 350, causing the arginine (R) at amino acid position 117 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Centre de Biologie Pathologie Génétique, |
RCV001252159 | SCV001427909 | likely benign | Intellectual disability | 2019-01-01 | no assertion criteria provided | clinical testing |